Is there another benefit besides weight loss of GLP-1s in people with severe obesity? Elizabeth Tracey reports
From Health Newsfeed – Johns Hopkins Medicine Podcasts by Johns Hopkins Medicine
April 23, 2026 · 1 min
About this episode
The episode discusses the potential additional benefits of GLP-1 receptor agonists for individuals with severe obesity and heart failure.
GLP-1 receptor agonists are effective in helping most people lose weight, and now a new study suggests that in those with severe obesity, a BMI of 42 or greater and who have a type of heart failure, this condition may … Is there another benefit besides weight loss of GLP-1s in people with severe obesity? Elizabeth Tracey reports Read More »
People in this episode
Host: Elizabeth Tracey
Topics covered
- GLP-1 receptor agonists
- severe obesity
- weight loss
- heart failure
- BMI
- health benefits
Keywords
- GLP-1
- weight loss
- severe obesity
- heart failure
- BMI
- health benefits
- Johns Hopkins
Mentioned in this episode
Organizations: Johns Hopkins Medicine
Products: GLP-1 receptor agonists
More episodes of Health Newsfeed – Johns Hopkins Medicine Podcasts
- An AI model may help predict who is more likely to develop pancreas cancer, Elizabeth Tracey reports · June 11, 2026 · 1 min
- Will GLP1 drugs tease out the relationship between insulin and cancer? Elizabeth Tracey reports · June 11, 2026 · 1 min
- Is there a relationship between diet, obesity and colorectal cancer? Elizabeth Tracey reports · June 11, 2026 · 1 min
- What accounts for increases in colorectal cancer among younger people? Elizabeth Tracey reports · June 11, 2026 · 1 min
- A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports · June 11, 2026 · 1 min
- A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports · June 8, 2026 · 1 min
Explore listener stats, chart rankings, contacts and more on the Health Newsfeed – Johns Hopkins Medicine Podcasts podcast page.